Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
February 11, 2025 07:58 ET
|
Aclarion, Inc.
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
February 06, 2025 07:23 ET
|
Aclarion, Inc.
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
February 04, 2025 07:23 ET
|
Aclarion, Inc.
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
January 31, 2025 11:59 ET
|
Aclarion, Inc.
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
November 21, 2024 08:00 ET
|
Aclarion, Inc.
Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by Siemens to...
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
October 10, 2024 07:00 ET
|
Aclarion, Inc.
Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
September 27, 2024 06:57 ET
|
Aclarion, Inc.
Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can Clarify...
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
September 13, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
September 12, 2024 06:57 ET
|
Aclarion, Inc.
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing...
Aclarion Added to PRISM Emerging Medical Devices Index
September 06, 2024 11:27 ET
|
PRISM MarketView
Aclarion Added to PRISM Emerging Medical Devices Index